Benzyl Isothiocyanate Alters the Gene Expression with Cell Cycle Regulation and Cell Death in Human Brain Glioblastoma GBM 8401 Cells

Total Page:16

File Type:pdf, Size:1020Kb

Benzyl Isothiocyanate Alters the Gene Expression with Cell Cycle Regulation and Cell Death in Human Brain Glioblastoma GBM 8401 Cells ONCOLOGY REPORTS 35: 2089-2096, 2016 Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells NOU-YING TANG1, FU-SHIN CHUEH2, CHIEN-CHIH YU3, CHING-LUNG LIAO1, JEN-JYH LIN4, TE-CHUN HSIA5, KING-CHUEN WU6, HSIN-CHUNG LIU7, KUNG-WEN LU8* and JING-GUNG CHUNG7,9* 1School of Chinese Medicine, China Medical University, Taichung 404; 2Department of Health and Nutrition Biotechnology, Asia University, Taichung 413; 3School of Pharmacy, China Medical University, Taichung 404; 4Division of Cardiology and 5Department of Internal Medicine, China Medical University Hospital, Taichung 404; 6Department of Anesthesiology, E-Da Hospital/I-Shou University, Kaohsiung 824, Taiwan; 7Department of Biological Science and Technology, and 8School of Post-Baccalaureate Chinese Medicine, China Medical University, Taichung 404; 9Department of Biotechnology, Asia University, Taichung 413, Taiwan, R.O.C. Received November 3, 2015; Accepted December 12, 2015 DOI: 10.3892/or.2016.4577 Abstract. Glioblastoma multiforme (GBM) is a highly malig- downregulated and two genes were associated with receptor nant devastating brain tumor in adults. Benzyl isothiocyanate for cell responses to stimuli, the EGF containing fibulin-like (BITC) is one of the isothiocyanates that have been shown extracellular matrix protein 1 (EFEMP1) was inhibited 2.01- to induce human cancer cell apoptosis and cell cycle arrest. fold and the TNF receptor-associated protein 1 (TRAP1) Herein, the effect of BITC on cell viability and apoptotic cell was inhibited 2.08-fold. BITC inhibited seven mitochondria death and the genetic levels of human brain glioblastoma ribosomal genes, the mitochondrial ribosomal protein; tumor GBM 8401 cells in vitro were investigated. We found that protein D52 (MRPS28) was inhibited 2.06-fold, the mitochon- BITC induced cell morphological changes, decreased cell dria ribosomal protein S2 (MRPS2) decreased 2.07-fold, the viability and the induction of cell apoptosis in GBM 8401 mitochondria ribosomal protein L23 (MRPL23) decreased cells was time-dependent. cDNA microarray was used to 2.08-fold, the mitochondria ribosomal protein S2 (MRPS2) examine the effects of BITC on GBM 8401 cells and we decreased 2.07-fold, the mitochondria ribosomal protein S12 found that numerous genes associated with cell death and (MRPS12) decreased 2.08-fold, the mitochondria ribosomal cell cycle regulation in GBM 8401 cells were altered after protein L12 (MRPL12) decreased 2.25-fold and the mito- BITC treatment. The results show that expression of 317 chondria ribosomal protein S34 (MRPS34) was decreased genes was upregulated, and two genes were associated 2.30-fold in GBM 8401 cells. These changes of gene expres- with DNA damage, the DNA-damage-inducible transcript sion can provide the effects of BITC on the genetic level and 3 (DDIT3) was increased 3.66-fold and the growth arrest are potential biomarkers for glioblastoma therapy. and DNA-damage-inducible α (GADD45A) was increased 2.34-fold. We also found that expression of 182 genes was Introduction Glioblastomas are the most frequent and aggressive primary brain cancers in adults (1) with a high recurrence and mortality rate (2). Glioblastoma prognosis is poor and there Correspondence to: Professor Jing-Gung Chung, Department are limited therapeutic options. In recent years, advances have of Biological Science and Technology, China Medical University, been made in multimodality including surgery, radiotherapy, 91 Hsueh-Shih Road, Taichung 404, Taiwan, R.O.C. E-mail: [email protected] chemotherapy and biotherapy, but the overall 5-year survival rate is still <3% for patients with glioblastoma (3). Thus, we Professor Kung-Wen Lu, School of Post-Baccalaureate Chinese try to identify prognostic gene expression (upregulation or Medicine, China Medical University, 91 Hsueh-Shih Road, Taichung downregulation) that may contribute to evaluate a more effec- 404, Taiwan, R.O.C. tive treatment to improve patient survival and to address more E-mail: [email protected] precisely the use of comprehensive therapy. *Contributed equally Benzyl isothiocyanate (BITC), one of the isothio- cyanates, is present in cruciferous plants, it acts against Key words: benzyl isothiocyanate, gene, cell cycle arrest, regulation, carcinogenesis (4,5) and induces cell death through the glioblastoma induction of apoptosis and cell cycle arrest in various human cancer cells (6-10). In human prostate cancer cells, BITC promoted the phosphorylation of Bcl-xL with simultaneous 2090 tang et al: BITC changes gene EXpression and protein leVels in GBM 8401 cells cell cycle arrest and subsequent apoptosis (11). In our cDNA microarray assay for gene expression. GBM 8401 previous studies we have demonstrated that BITC inhibited cells (2.4x106 cells/dish) were maintained in a 10 cm dish migration and invasion in human colon (12) and gastric (13) for 24 h. Cells were treated with 6 µM BITC or DMSO for cancer cells in vitro. There is no available information to 48 h then cells were collected, and washed twice with PBS. show whether BITC affects human brain tumor cells, in All samples were further isolated in total RNA using Qiagen particular regarding the effects of BITC on gene expression RNeasy Mini kit (Qiagen, Valencia, CA, USA). The isolated in human glioblastoma cells. RNA was further conducted for cDNA synthesis, labeling In cell survival, to maintain the integrity of genomic and and microarray hybridization. The fluorescent-labeled cDNA mitochondrial DNA is critically important. It was reported hybridization (Affymetrix GeneChip Human Gene 1.0 ST that damage to nuclear and mitochondrial DNA can increase array; Affymetrix, Santa Clara, CA, USA) on the chip was the accumulation of defective cellular components leading conducted (18), and the fluorescence from each sample was to impact unfavorably on physiological functions, increasing measured by Asia BioInnovations Corporation (Taipei, entropy (14). If an agent induces DNA damage, the cell in order Taiwan). Expression Console software (Affymetrix) with to respond to the DNA damage, activates the cell cycle check- default RNA parameters (19,20) was used to analyze the data. points (G1, S and G2/M) to stop cell cycle progression in order BITC affecting gene expression with at least a 2-fold-change to allow time for repair, thereby preventing transmission of was considered significant and recorded. damaged or incompletely replicated chromosomes (15). Thus, the associated gene expression regarding cell cycle progres- Results sion, cell apoptosis and DNA damage in cells are important for cancer cell therapy. There is no previous study showing the Cytotoxic effects of BITC in GBM 8401 cells. To investigate anticancer properties of BITC at the genetic level of human the cytotoxic effects of BITC in GBM 8401 cells, after treat- glioblastoma. We investigated the effects of BITC on gene ment of cells with 6 µM BITC for 0, 12, 24 and 48 h, the expression in human brain cancer glioblastoma multiforme cell morphological changes and percentage of viable cells (GBM 8401) in vitro. were measured and results are presented in Fig. 1A and B, respectively. BITC induced cell morphological changes and Materials and methods decreased cell viability in GBM 8401 cells and these effects are time-dependent (Fig. 1A and B). Chemicals and reagents. BITC, dimethyl sulfoxide (DMSO), penicillin-streptomycin and trypsin-EDTA were obtained from Induction of cell apoptosis in GBM 8401 cells after exposure Sigma Chemical Co. (St. Louis, MO, USA). RPMI-1640 culture to BITC. In order to further examine whether cell death was medium and fetal bovine serum (FBS) were purchased from induced by BITC and through the induction of cell apoptosis, Gibco-BRL/Invitrogen (Carlsbad, CA, USA). Tissue culture the cells after treatment with 6 µM BITC were harvested and flasks and plates were obtained from Gibco-BRL/Invitrogen. apoptotic cells were measured by Annexin V/PI staining, and the results are presented in Fig. 2. Based on the data in Cell culture. Human brain glioblastoma GBM 8401 cells were Fig. 2, BITC-induced apoptotic cell death and these effects are purchased from the Food Industry Research and Development time-dependent. The treatment of cells with BITC increased Institute (Hsinchu, Taiwan) and cultured following the the total apoptotic cell death to 36.81% at 48 h (Table I). The supplier's instructions. Cells were grown in 75 cm2 culture result is consistent with the morphology and examination of flasks with RPMI-1640 medium supplemented with 10% FBS, total viable cells. 100 U/ml penicillin and 100 µg/ml streptomycin and main- tained in an atmosphere of 5% CO2 and 95% air at 37˚C. The BITC alters the regulations of gene expression in GBM 8401 medium was changed every 2 days (16). cells. GBM 8401 cells were treated with or without 6 µM BITC for 48 h and then harvested for total RNA extraction. Cell morphological changes and viability assays. GBM 8401 The expression of the top 10 up- and downregulated genes was cells (8x104 cells/ml) were seeded into a 12-well plate estimated by cDNA microarray analysis and the results are containing RPMI-1640 medium for 24 h. In addition, BITC presented in Tables II and III. BITC induced 317 upregulated was added to wells at the final concentration of 6 µM for 0, 12, genes and 182 downregulated genes of GBM 8401, respectively. 24 and 48 h. After treatment, cells were examined and photo- Fourty-six genes were upregulated in the range >3-<4-fold, graphed using contrast-phase microscopy at a magnification of and 198 genes were upregulated >2-<3-fold. One gene was x400 and then harvested for measuring the total percentage of downregulated >4-fold, and 11 genes were downregulated viable cells using flow cytometric assay (16). in the range >3-<4-fold, and 170 genes were downregulated >2-<3-fold (data not shown). Annexin V/PI staining for cell apoptosis.
Recommended publications
  • Role of Mitochondrial Ribosomal Protein S18-2 in Cancerogenesis and in Regulation of Stemness and Differentiation
    From THE DEPARTMENT OF MICROBIOLOGY TUMOR AND CELL BIOLOGY (MTC) Karolinska Institutet, Stockholm, Sweden ROLE OF MITOCHONDRIAL RIBOSOMAL PROTEIN S18-2 IN CANCEROGENESIS AND IN REGULATION OF STEMNESS AND DIFFERENTIATION Muhammad Mushtaq Stockholm 2017 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-Print AB 2017 © Muhammad Mushtaq, 2017 ISBN 978-91-7676-697-2 Role of Mitochondrial Ribosomal Protein S18-2 in Cancerogenesis and in Regulation of Stemness and Differentiation THESIS FOR DOCTORAL DEGREE (Ph.D.) By Muhammad Mushtaq Principal Supervisor: Faculty Opponent: Associate Professor Elena Kashuba Professor Pramod Kumar Srivastava Karolinska Institutet University of Connecticut Department of Microbiology Tumor and Cell Center for Immunotherapy of Cancer and Biology (MTC) Infectious Diseases Co-supervisor(s): Examination Board: Professor Sonia Lain Professor Ola Söderberg Karolinska Institutet Uppsala University Department of Microbiology Tumor and Cell Department of Immunology, Genetics and Biology (MTC) Pathology (IGP) Professor George Klein Professor Boris Zhivotovsky Karolinska Institutet Karolinska Institutet Department of Microbiology Tumor and Cell Institute of Environmental Medicine (IMM) Biology (MTC) Professor Lars-Gunnar Larsson Karolinska Institutet Department of Microbiology Tumor and Cell Biology (MTC) Dedicated to my parents ABSTRACT Mitochondria carry their own ribosomes (mitoribosomes) for the translation of mRNA encoded by mitochondrial DNA. The architecture of mitoribosomes is mainly composed of mitochondrial ribosomal proteins (MRPs), which are encoded by nuclear genomic DNA. Emerging experimental evidences reveal that several MRPs are multifunctional and they exhibit important extra-mitochondrial functions, such as involvement in apoptosis, protein biosynthesis and signal transduction. Dysregulations of the MRPs are associated with severe pathological conditions, including cancer.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Chapter 4.1 a 400 Kb Duplication, 2.4 Mb Triplication and 130 Kb
    High-resolution karyotyping by oligonucleotide microarrays : the next revolution in cytogenetics Gijsbers, A.C.J. Citation Gijsbers, A. C. J. (2010, November 30). High-resolution karyotyping by oligonucleotide microarrays : the next revolution in cytogenetics. Retrieved from https://hdl.handle.net/1887/16187 Version: Corrected Publisher’s Version Licence agreement concerning inclusion of doctoral thesis in the License: Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/16187 Note: To cite this publication please use the final published version (if applicable). Chapter 4.1 A 400 kb duplication, 2.4 Mb triplication and 130 kb duplication of 9q34.3 in a patient with severe mental retardation Antoinet CJ Gijsbers, Emilia K Bijlsma, Marjan M Weiss, Egbert Bakker, Martijn H Breuning, Mariëtte JV Hoffer and Claudia AL Ruivenkamp Center for Human and Clinical Genetics; Leiden University Medical Center (LUMC), Leiden, The Netherlands Eur J Med Genet 2008;51:479-487 Chapter 4 Abstract The presence of a duplication as well as a triplication in one chromosome is a rare rearrangement and not easy to distinguish with routine chromosomal analysis. Recent developments in array technologies, however, not only allow screening of the whole genome at a higher resolution, but also make it possible to characterize complex chromosomal rearrangements in more detail. Here we report a molecular cytogenetic analysis of a 16-year old female with severe mental retardation and an abnormality on the end of the long arm of chromosome 9. Subtelomeric multiplex ligation-dependent probe amplification (MLPA) analysis revealed that the extra material originated from the telomeric end of chromosome 9q.
    [Show full text]
  • PDF Output of CLIC (Clustering by Inferred Co-Expression)
    PDF Output of CLIC (clustering by inferred co-expression) Dataset: Num of genes in input gene set: 13 Total number of genes: 16493 CLIC PDF output has three sections: 1) Overview of Co-Expression Modules (CEMs) Heatmap shows pairwise correlations between all genes in the input query gene set. Red lines shows the partition of input genes into CEMs, ordered by CEM strength. Each row shows one gene, and the brightness of squares indicates its correlations with other genes. Gene symbols are shown at left side and on the top of the heatmap. 2) Details of each CEM and its expansion CEM+ Top panel shows the posterior selection probability (dataset weights) for top GEO series datasets. Bottom panel shows the CEM genes (blue rows) as well as expanded CEM+ genes (green rows). Each column is one GEO series dataset, sorted by their posterior probability of being selected. The brightness of squares indicates the gene's correlations with CEM genes in the corresponding dataset. CEM+ includes genes that co-express with CEM genes in high-weight datasets, measured by LLR score. 3) Details of each GEO series dataset and its expression profile: Top panel shows the detailed information (e.g. title, summary) for the GEO series dataset. Bottom panel shows the background distribution and the expression profile for CEM genes in this dataset. Overview of Co-Expression Modules (CEMs) with Dataset Weighting Scale of average Pearson correlations Num of Genes in Query Geneset: 13. Num of CEMs: 1. 0.0 0.2 0.4 0.6 0.8 1.0 Rps29 Rps28 Fau Rps6 Mrps2 Rps18 Mrps6 Rps25
    [Show full text]
  • Supplementary Dataset S2
    mitochondrial translational termination MRPL28 MRPS26 6 MRPS21 PTCD3 MTRF1L 4 MRPL50 MRPS18A MRPS17 2 MRPL20 MRPL52 0 MRPL17 MRPS33 MRPS15 −2 MRPL45 MRPL30 MRPS27 AURKAIP1 MRPL18 MRPL3 MRPS6 MRPS18B MRPL41 MRPS2 MRPL34 GADD45GIP1 ERAL1 MRPL37 MRPS10 MRPL42 MRPL19 MRPS35 MRPL9 MRPL24 MRPS5 MRPL44 MRPS23 MRPS25 ITB ITB ITB ITB ICa ICr ITL original ICr ICa ITL ICa ITL original ICr ITL ICr ICa mitochondrial translational elongation MRPL28 MRPS26 6 MRPS21 PTCD3 MRPS18A 4 MRPS17 MRPL20 2 MRPS15 MRPL45 MRPL52 0 MRPS33 MRPL30 −2 MRPS27 AURKAIP1 MRPS10 MRPL42 MRPL19 MRPL18 MRPL3 MRPS6 MRPL24 MRPS35 MRPL9 MRPS18B MRPL41 MRPS2 MRPL34 MRPS5 MRPL44 MRPS23 MRPS25 MRPL50 MRPL17 GADD45GIP1 ERAL1 MRPL37 ITB ITB ITB ITB ICa ICr original ICr ITL ICa ITL ICa ITL original ICr ITL ICr ICa translational termination MRPL28 MRPS26 6 MRPS21 PTCD3 C12orf65 4 MTRF1L MRPL50 MRPS18A 2 MRPS17 MRPL20 0 MRPL52 MRPL17 MRPS33 −2 MRPS15 MRPL45 MRPL30 MRPS27 AURKAIP1 MRPL18 MRPL3 MRPS6 MRPS18B MRPL41 MRPS2 MRPL34 GADD45GIP1 ERAL1 MRPL37 MRPS10 MRPL42 MRPL19 MRPS35 MRPL9 MRPL24 MRPS5 MRPL44 MRPS23 MRPS25 ITB ITB ITB ITB ICa ICr original ICr ITL ICa ITL ICa ITL original ICr ITL ICr ICa translational elongation DIO2 MRPS18B MRPL41 6 MRPS2 MRPL34 GADD45GIP1 4 ERAL1 MRPL37 2 MRPS10 MRPL42 MRPL19 0 MRPL30 MRPS27 AURKAIP1 −2 MRPL18 MRPL3 MRPS6 MRPS35 MRPL9 EEF2K MRPL50 MRPS5 MRPL44 MRPS23 MRPS25 MRPL24 MRPS33 MRPL52 EIF5A2 MRPL17 SECISBP2 MRPS15 MRPL45 MRPS18A MRPS17 MRPL20 MRPL28 MRPS26 MRPS21 PTCD3 ITB ITB ITB ITB ICa ICr ICr ITL original ITL ICa ICa ITL ICr ICr ICa original
    [Show full text]
  • Structural Basis of Mitochondrial Translation Shintaro Aibara1†, Vivek Singh1,2, Angelika Modelska3‡, Alexey Amunts1,2*
    RESEARCH ARTICLE Structural basis of mitochondrial translation Shintaro Aibara1†, Vivek Singh1,2, Angelika Modelska3‡, Alexey Amunts1,2* 1Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden; 2Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; 3Laboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento, Italy Abstract Translation of mitochondrial messenger RNA (mt-mRNA) is performed by distinct mitoribosomes comprising at least 36 mitochondria-specific proteins. How these mitoribosomal proteins assist in the binding of mt-mRNA and to what extent they are involved in the translocation of transfer RNA (mt-tRNA) is unclear. To visualize the process of translation in human mitochondria, we report ~3.0 A˚ resolution structure of the human mitoribosome, including the L7/L12 stalk, and eight structures of its functional complexes with mt-mRNA, mt-tRNAs, recycling factor and additional trans factors. The study reveals a transacting protein module LRPPRC-SLIRP that delivers mt-mRNA to the mitoribosomal small subunit through a dedicated platform formed by the mitochondria-specific protein mS39. Mitoribosomal proteins of the large subunit mL40, mL48, and *For correspondence: mL64 coordinate translocation of mt-tRNA. The comparison between those structures shows [email protected] dynamic interactions between the mitoribosome and its ligands, suggesting a sequential Present address: †Department mechanism of conformational changes. of Molecular Biology, Max- Planck-Institute for BiophysicalChemistry, Go¨ ttingen, Germany; ‡Aix Marseille Introduction Universite´, CNRS, INSERM, Translation in humans takes place in the cytosol and mitochondria. Mitochondrial translation is Centre d’Immunologie responsible for the maintenance of the cellular energetic balance through synthesis of proteins deMarseille-Luminy (CIML), Marseille, France involved in oxidative phosphorylation.
    [Show full text]
  • Comparative Host-Coronavirus Protein Interaction Networks Reveal Pan
    Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms David Gordon, Joseph Hiatt, Mehdi Bouhaddou, Veronica Rezelj, Svenja Ulferts, Hannes Braberg, Alexander Jureka, Kirsten Obernier, Jeffrey Guo, Jyoti Batra, et al. To cite this version: David Gordon, Joseph Hiatt, Mehdi Bouhaddou, Veronica Rezelj, Svenja Ulferts, et al.. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, American Association for the Advancement of Science, 2020, 370 (6521), pp.eabe9403. 10.1126/science.abe9403. hal-03102291 HAL Id: hal-03102291 https://hal.archives-ouvertes.fr/hal-03102291 Submitted on 7 Jan 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Corrected 21 December 2020. See full text. RESEARCH ◥ RESULTS: Quantitative comparison of the 389 RESEARCH ARTICLE SUMMARY interactors of SARS-CoV-2, 366 of SARS-CoV-1, and 296 of MERS-CoV highlighted interactions CORONAVIRUS with host processes that are conserved across all three viruses, including where nonortholo- Comparative host-coronavirus protein interaction gous proteins from different virus strains seem to fill similar roles. We also localized each networks reveal pan-viral disease mechanisms individually-expressed viral protein by micros- copy and then raised and validated antisera David E.
    [Show full text]
  • A Novel 2.3 Mb Microduplication of 9Q34. 3 Inserted Into 19Q13. 4 in A
    Hindawi Publishing Corporation Case Reports in Pediatrics Volume 2012, Article ID 459602, 7 pages doi:10.1155/2012/459602 Case Report A Novel 2.3 Mb Microduplication of 9q34.3 Inserted into 19q13.4 in a Patient with Learning Disabilities Shalinder Singh,1 Fern Ashton,1 Renate Marquis-Nicholson,1 Jennifer M. Love,1 Chuan-Ching Lan,1 Salim Aftimos,2 Alice M. George,1 and Donald R. Love1, 3 1 Diagnostic Genetics, LabPlus, Auckland City Hospital, P.O. Box 110031, Auckland 1148, New Zealand 2 Genetic Health Service New Zealand-Northern Hub, Auckland City Hospital, Private Bag 92024, Auckland 1142, New Zealand 3 School of Biological Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand Correspondence should be addressed to Donald R. Love, [email protected] Received 1 July 2012; Accepted 27 September 2012 Academic Editors: L. Cvitanovic-Sojat, G. Singer, and V. C. Wong Copyright © 2012 Shalinder Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Insertional translocations in which a duplicated region of one chromosome is inserted into another chromosome are very rare. We report a 16.5-year-old girl with a terminal duplication at 9q34.3 of paternal origin inserted into 19q13.4. Chromosomal analysis revealed the karyotype 46,XX,der(19)ins(19;9)(q13.4;q34.3q34.3)pat. Cytogenetic microarray analysis (CMA) identified a ∼2.3Mb duplication of 9q34.3 → qter, which was confirmed by Fluorescence in situ hybridisation (FISH).
    [Show full text]
  • A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
    Article A SARS-CoV-2 protein interaction map reveals targets for drug repurposing https://doi.org/10.1038/s41586-020-2286-9 A list of authors and affiliations appears at the end of the paper Received: 23 March 2020 Accepted: 22 April 2020 A newly described coronavirus named severe acute respiratory syndrome Published online: 30 April 2020 coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than Check for updates 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efcacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and eforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identifed the human proteins that physically associated with each of the SARS-CoV-2 proteins using afnity-purifcation mass spectrometry, identifying 332 high-confdence protein–protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.
    [Show full text]
  • Transcriptomic and Proteomic Landscape of Mitochondrial
    TOOLS AND RESOURCES Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals Inge Ku¨ hl1,2†*, Maria Miranda1†, Ilian Atanassov3, Irina Kuznetsova4,5, Yvonne Hinze3, Arnaud Mourier6, Aleksandra Filipovska4,5, Nils-Go¨ ran Larsson1,7* 1Department of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany; 2Department of Cell Biology, Institute of Integrative Biology of the Cell (I2BC) UMR9198, CEA, CNRS, Univ. Paris-Sud, Universite´ Paris-Saclay, Gif- sur-Yvette, France; 3Proteomics Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany; 4Harry Perkins Institute of Medical Research, The University of Western Australia, Nedlands, Australia; 5School of Molecular Sciences, The University of Western Australia, Crawley, Australia; 6The Centre National de la Recherche Scientifique, Institut de Biochimie et Ge´ne´tique Cellulaires, Universite´ de Bordeaux, Bordeaux, France; 7Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden Abstract Dysfunction of the oxidative phosphorylation (OXPHOS) system is a major cause of human disease and the cellular consequences are highly complex. Here, we present comparative *For correspondence: analyses of mitochondrial proteomes, cellular transcriptomes and targeted metabolomics of five [email protected] knockout mouse strains deficient in essential factors required for mitochondrial DNA gene (IKu¨ ); expression, leading to OXPHOS dysfunction. Moreover,
    [Show full text]